The 26 references in paper A. Kadushkin G., T. Shman V., M. Belevtsev V., Zh. Ibragimova A., A. Taganovich D., А. Кадушкин Г., Т. Шман В., М. Белевцев В., Ж. Ибрагимова А., А. Таганович Д. (2014) “Популяционная перестройка Т-лимфоцитов, содержащих хемокиновые рецепторы, у пациентов с хронической обструктивной болезнью легких // Changes in T-lymphocyte population containing chemokine receptors in patients with chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2013:i:2:p:41-45

1
Salvi S.S., Barnes P.J. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374: 733–743.
(check this in PDF content)
2
Murray C.J., Lopez A.D. Alternative projections of mortality and disability by course 1990–2020: Global Burden of Disease Study. Lancet 1997; 349: 1498–1504.
(check this in PDF content)
3
Halbert R.J., Natoli J.L., Gano A. et al.Global burden of COPD: systematic review and meta-analysis. Eur. Respir. J. 2006; 28 (3): 523–532.
(check this in PDF content)
4
Zhou Y., Wang C., Yao W. et al.COPD in Chinese nonsmokers. Eur. Respir. J. 2009; 33: 509–518.
(check this in PDF content)
5
Gunen H., Hacievliyagil S.S., Yetkin O. et al. Prevalence of COPD: First epidemiological study of a large region in Turkey. Eur. J. Intern. Med. 2008; 19 (7): 499–504.
(check this in PDF content)
6
Кадушкин А.Г., Таганович А.Д. Молекулярно-клеточные механизмы развития хронической обструктивной болезни легких. Воен. мед. 2012; 1: 132–138.
(check this in PDF content)
7
Bonecchi R., Bianchi G., Bordignon P.P. et al.Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998; 187 (1): 129–134.
(check this in PDF content)
8
Wan P., Zhong X.N., He Z.Y. et al.The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease. Zhonghua Nei Ke Za Zhi 2009; 48 (10): 841–845.
(check this in PDF content)
9
Freeman С.M., Curtis J.L., Chensue S.W.CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+cells correlates with chronic obstructive pulmonary disease severity. Am. J. Pathol. 2007; 171 (3): 767–776.
(check this in PDF content)
10
Di Stefano A., Capelli A., Lusuardi M. et al.Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin. Exp. Allergy 2001; 31 (6): 893–902.
(check this in PDF content)
11
Koch A., Gaczkowski M., Sturton G. et al. Modification of surface antigens in blood CD8+T-lymphocytes in COPD: effects of smoking. Eur. Respir. J. 2007; 29: 42–50.
(check this in PDF content)
12
Bronzyna S., Ahern J., Hodge J. et al.Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients. COPD 2009; 6 (1): 4–16.
(check this in PDF content)
13
World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Geneva: WHO; 2008.
(check this in PDF content)
14
Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global initiative for chronic obstructive lung disease (GOLD); 2011.
(check this in PDF content)
15
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global initiative for chronic obstructive lung disease (GOLD); 2009.
(check this in PDF content)
16
Wanger J., Clausen J.L., Coates A. et al. Standartisation of the measurement of lung volumes. Eur. Respir. J. 2005; 26: 511–522.
(check this in PDF content)
17
Smyth L.J., Starkey C., Vestbo J. et al. CD4-regulatory cells in COPD patients. Chest 2007; 132 (1): 156–163.
(check this in PDF content)
18
Domagala+Kulawik J., Hoser G., Dabrowska M. et al. CD4+/ CD25+cells in systemic inflammation in COPD. Scand. J. Immunol. 2011; 73 (1): 59–65.
(check this in PDF content)
19
Domagala+Kulawik J., Hoser G., Dabrowska M. et al.Fas+ lymphocytes and CD4+/ CD25+cells in peripheral blood of never smoking patients with chronic obstructive pulmonary disease. Centr. Eur. J. Immunol. 2011; 36 (4): 226–232.
(check this in PDF content)
20
Muehlinghaus G., Cigliano L., Huehn S. et al. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 2005; 105 (10): 3965–3971.
(check this in PDF content)
21
Inngjerdingen M., Damaj B., Maghazachi A.A.Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001; 97 (2): 367–375.
(check this in PDF content)
22
Barnes P.J. Distribution of receptor targets in the lung. Proc. Am. Thorac. Soc. 2004; 1 (4): 345–351.
(check this in PDF content)
23
Scholten D.J., Canals M., Maussang D. et al. Pharmacological modulation of chemokine receptor function. Br. J. Pharmacol. 2012; 165 (6): 1617–1643.
(check this in PDF content)
24
Кадушкин А.Г., Таганович А.Д. Роль хемокинов в патогенезе хронической обструктивной болезни легких. Мед. журн. 2012; 2: 139–144.
(check this in PDF content)
25
O'Boyle G., Fox C.R., Walden H.R. et al.Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation. Proc. Natl Acad. Sci. USA 2012; 109 (12): 4598–4603. Информация об авторах Кадушкин Алексей Геннадьевич– аспирант кафедры биологической химии УО "Белорусский государственный медицинский университет"; тел.: (37517) 272-67-88; e-mail: kadushkyn@gmail.com Шман Татьяна Викторовна – к. б. н., зав. лабораторией иммунологических исследований ГУ "Республиканский научно\u0018практический центр детской онкологии, гематологии и иммунологии"; тел.: (37517)
(check this in PDF content)
26
42-22; e-mail: shman@oncology.by Белевцев Михаил Владимирович– к. б. н., зам. директора по научной работе ГУ "Республиканский научно\u0018практический центр детской он\u0018 кологии, гематологии и иммунологии"; тел.: (37517) 265\u001848\u001861; e\u0018mail: belevtsev_m@mail.ru
(check this in PDF content)